Case-by-Case Peptide Screen
Test the need, evidence, and alternatives before using a peptide
- Difficulty
- Easy
- Time to result
- ~days to results
- Steps
- 4
- Confidence
- 88%
The Case-by-Case Peptide Screen replaces category-level enthusiasm with an outcome-led decision. First identify the exact reason for considering a peptide and the change it is supposed to produce. Then inspect the evidence for that specific compound, separating rodent findings from the smaller body of human research and checking restrictions that matter to the user. Finally, compare safer or better-established ways to invoke the same change before deciding. Dr. Stacy Sims uses BPC 157 as the bounded example: it has tissue-healing evidence, but many other peptides are circulating without much science behind them. The output is not a blanket yes or no; it is a compound-specific decision proportional to the evidence, purpose, and alternatives.
Origin
Dr. Stacy Sims outlined this case-by-case screen while discussing the uneven evidence behind peptides, using BPC 157 for tissue healing as her clearest example.
Core principles
- 01Judge each peptide separately rather than treating the category as proven
- 02Start with the outcome the person is trying to achieve
- 03Prefer established alternatives that can invoke the same change
- 04Match confidence to the amount of human evidence
How to run it
- 1
Define the purpose
Write down why the peptide is being considered and the concrete outcome expected from it.
Pro tip Use an observable outcome such as tissue healing rather than a vague goal such as optimization.
Watch out Do not let general peptide hype stand in for a specific need.
- 2
Grade the evidence
Review the research for that compound and distinguish human evidence from animal data. Note whether relevant sport bodies prohibit it.
Pro tip Treat a little human research differently from a large, mature evidence base.
Watch out A banned status may signal biological activity, but it does not by itself establish safety or suitability.
- 3
Map the alternatives
Identify training, nutrition, rehabilitation, or established clinical options that could invoke the same desired change.
Pro tip Compare options against the same target outcome.
Watch out Do not assume a peptide is necessary merely because it might work.
- 4
Make a bounded decision
Decide case by case with professional input, matching the strength of the decision to the quality of the evidence and the user's context.
Watch out Avoid extending evidence for one peptide to unrelated compounds.
In the wild
A recreational athlete asks about BPC 157 after a tissue injury. They define tissue healing as the target, note that Sims describes substantial rodent data but only a little human research, check that relevant sport authorities ban it, and compare it with a conventional rehabilitation plan before consulting a clinician.
→ The athlete makes a purpose-specific decision without assuming that all peptides are validated.
Common mistakes
Treating peptides as one category
Evidence for one compound and one use does not validate every peptide or every claimed benefit.
Skipping the alternatives
Considering only the peptide hides other ways to produce the same change with better-established methods.
Is it for you?
Best for
It is best for someone considering a peptide for a specific recovery or performance outcome.
Not ideal for
It is not a substitute for medical diagnosis, prescribing, or individual risk assessment.
From the transcript
“Um yeah, so that's another one would be a case by case. It's like why do you want to use it? What do you think…”
“So if you look at the uh BPC 157 which is your right. Yeah. So, if you're looking at that for tissue healing, there's a…”
From the episode
Episode 468: Dr. Stacy Sims: Why Ozempic Destroys Muscle + The Truth About Peptides and Cold Plunges
Dr. Stacy Sims